vs
CorMedix Inc.（CRMD）与LiveRamp Holdings, Inc.（RAMP）财务数据对比。点击上方公司名可切换其他公司
LiveRamp Holdings, Inc.的季度营收约是CorMedix Inc.的1.6倍（$212.2M vs $128.6M）
CorMedix Inc.是一家处于商业阶段的生物制药企业，专注于开发及商业化用于预防和治疗感染性、炎症性及心肾疾病的创新治疗产品，核心管线针对导管相关血流感染，主要服务北美、欧洲的重症监护及长期透析患者群体。
LiveRamp Holdings, Inc.是一家美国SaaS企业，核心业务为提供数据连接平台，服务涵盖数据导入、线下数据线上迁移等能力，助力企业开展营销相关的数据应用，为品牌及营销从业者的数字化运营提供技术支撑。
CRMD vs RAMP — 直观对比
营收规模更大
RAMP
是对方的1.6倍
$128.6M
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $128.6M | $212.2M |
| 净利润 | — | $39.9M |
| 毛利率 | 83.4% | 71.9% |
| 营业利润率 | 46.0% | 18.6% |
| 净利率 | — | 18.8% |
| 营收同比 | — | 8.6% |
| 净利润同比 | — | 255.7% |
| 每股收益（稀释后） | $0.20 | $0.62 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CRMDRAMP
| Q4 25 | $128.6M | $212.2M | ||
| Q3 25 | $104.3M | $199.8M | ||
| Q2 25 | $39.7M | $194.8M | ||
| Q1 25 | $39.1M | $188.7M | ||
| Q4 24 | — | $195.4M | ||
| Q3 24 | — | $185.5M | ||
| Q2 24 | — | $176.0M | ||
| Q1 24 | — | $171.9M |
净利润CRMDRAMP
| Q4 25 | — | $39.9M | ||
| Q3 25 | $108.6M | $27.4M | ||
| Q2 25 | $19.8M | $7.7M | ||
| Q1 25 | $20.6M | $-6.3M | ||
| Q4 24 | — | $11.2M | ||
| Q3 24 | — | $1.7M | ||
| Q2 24 | — | $-7.5M | ||
| Q1 24 | — | $-5.4M |
毛利率CRMDRAMP
| Q4 25 | 83.4% | 71.9% | ||
| Q3 25 | 89.3% | 70.2% | ||
| Q2 25 | 95.3% | 70.1% | ||
| Q1 25 | 95.9% | 69.3% | ||
| Q4 24 | — | 71.9% | ||
| Q3 24 | — | 72.4% | ||
| Q2 24 | — | 70.6% | ||
| Q1 24 | — | 72.2% |
营业利润率CRMDRAMP
| Q4 25 | 46.0% | 18.6% | ||
| Q3 25 | 49.2% | 10.7% | ||
| Q2 25 | 49.2% | 3.7% | ||
| Q1 25 | 51.5% | -6.1% | ||
| Q4 24 | — | 7.5% | ||
| Q3 24 | — | 4.0% | ||
| Q2 24 | — | -3.0% | ||
| Q1 24 | — | -8.3% |
净利率CRMDRAMP
| Q4 25 | — | 18.8% | ||
| Q3 25 | 104.1% | 13.7% | ||
| Q2 25 | 49.9% | 4.0% | ||
| Q1 25 | 52.8% | -3.3% | ||
| Q4 24 | — | 5.7% | ||
| Q3 24 | — | 0.9% | ||
| Q2 24 | — | -4.3% | ||
| Q1 24 | — | -3.1% |
每股收益（稀释后）CRMDRAMP
| Q4 25 | $0.20 | $0.62 | ||
| Q3 25 | $1.26 | $0.42 | ||
| Q2 25 | $0.28 | $0.12 | ||
| Q1 25 | $0.30 | $-0.10 | ||
| Q4 24 | — | $0.17 | ||
| Q3 24 | — | $0.03 | ||
| Q2 24 | — | $-0.11 | ||
| Q1 24 | — | $-0.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $148.5M | $403.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $405.3M | $962.3M |
| 总资产 | $826.1M | $1.3B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CRMDRAMP
| Q4 25 | $148.5M | $403.4M | ||
| Q3 25 | $55.7M | $376.9M | ||
| Q2 25 | $190.7M | $371.1M | ||
| Q1 25 | $77.5M | $420.8M | ||
| Q4 24 | — | $384.3M | ||
| Q3 24 | — | $348.4M | ||
| Q2 24 | — | $342.7M | ||
| Q1 24 | — | $368.9M |
股东权益CRMDRAMP
| Q4 25 | $405.3M | $962.3M | ||
| Q3 25 | $374.1M | $943.8M | ||
| Q2 25 | $220.6M | $947.8M | ||
| Q1 25 | $114.9M | $948.9M | ||
| Q4 24 | — | $957.7M | ||
| Q3 24 | — | $932.1M | ||
| Q2 24 | — | $951.9M | ||
| Q1 24 | — | $949.1M |
总资产CRMDRAMP
| Q4 25 | $826.1M | $1.3B | ||
| Q3 25 | $750.9M | $1.2B | ||
| Q2 25 | $252.6M | $1.2B | ||
| Q1 25 | $149.6M | $1.3B | ||
| Q4 24 | — | $1.3B | ||
| Q3 24 | — | $1.2B | ||
| Q2 24 | — | $1.2B | ||
| Q1 24 | — | $1.2B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $94.5M | — |
| 自由现金流经营现金流 - 资本支出 | $92.7M | — |
| 自由现金流率自由现金流/营收 | 72.1% | — |
| 资本支出强度资本支出/营收 | 1.3% | 0.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $172.8M | — |
8季度趋势，按日历期对齐
经营现金流CRMDRAMP
| Q4 25 | $94.5M | — | ||
| Q3 25 | $30.9M | $57.4M | ||
| Q2 25 | $30.0M | $-15.8M | ||
| Q1 25 | $19.7M | — | ||
| Q4 24 | — | $45.1M | ||
| Q3 24 | — | $55.6M | ||
| Q2 24 | — | $-9.3M | ||
| Q1 24 | — | — |
自由现金流CRMDRAMP
| Q4 25 | $92.7M | — | ||
| Q3 25 | $30.4M | $56.8M | ||
| Q2 25 | $30.0M | $-16.2M | ||
| Q1 25 | $19.7M | — | ||
| Q4 24 | — | $44.8M | ||
| Q3 24 | — | $55.4M | ||
| Q2 24 | — | $-9.6M | ||
| Q1 24 | — | — |
自由现金流率CRMDRAMP
| Q4 25 | 72.1% | — | ||
| Q3 25 | 29.1% | 28.4% | ||
| Q2 25 | 75.4% | -8.3% | ||
| Q1 25 | 50.5% | — | ||
| Q4 24 | — | 22.9% | ||
| Q3 24 | — | 29.8% | ||
| Q2 24 | — | -5.4% | ||
| Q1 24 | — | — |
资本支出强度CRMDRAMP
| Q4 25 | 1.3% | 0.1% | ||
| Q3 25 | 0.5% | 0.3% | ||
| Q2 25 | 0.1% | 0.2% | ||
| Q1 25 | 0.0% | 0.2% | ||
| Q4 24 | — | 0.1% | ||
| Q3 24 | — | 0.1% | ||
| Q2 24 | — | 0.1% | ||
| Q1 24 | — | 1.0% |
现金转化率CRMDRAMP
| Q4 25 | — | — | ||
| Q3 25 | 0.28× | 2.09× | ||
| Q2 25 | 1.51× | -2.04× | ||
| Q1 25 | 0.96× | — | ||
| Q4 24 | — | 4.02× | ||
| Q3 24 | — | 32.10× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CRMD
| Acquisition Of Melinta | $52.9M | 41% |
| Melinta Portfolio | $45.5M | 35% |
| Other | $18.6M | 14% |
| Contract Revenue | $7.4M | 6% |
| BARDA Agreement | $4.2M | 3% |
RAMP
暂无分部数据
